Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet

Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

Nexstim: Stimulating Earnings Turnaround

Av Inderes
Nexstim

Nexstim is a medical technology company, whose transcranial magnetic stimulation technology is used in pre-operative brain mapping and to treat neurological diseases and disorders. This technologically advanced niche player has a commercialization in relatively early stages and has been loss-making throughout its history. This year we expect a profitable result, supported by a non-recurring license fee. Analyst Antti Siltanen guides through technology, income streams, business model, future outlook and valuation.

Content:
00:00 Introduction
00:12 Technology and innovation
03:06 How does the technology work?
04:31 Customers, business idea and income streams
05:50 Regulation, R&D, and approval of the technology
07:48 Company history
10:00 Business segments + new openings with technology licensing
13:45 Pros, cons and restrictions regarding the licensing deal with Magnus medical
17:31 Joint ventures with TMS clinics in the US
19:10 The nature of the investment in the clinic
20:07 Sales in detail
21:22 Sales organization
22:08 Potential and cost structure
23:27 Valuation
27:15 H1’22 comments

Graphics: Inderes and Nexstim

Read the latest research, published 2022-08-16:
https://www.inderes.se/research/stimulating-earnings-turnaround

Read more about Nexstim: https://www.inderes.se/companies/Nexstim

Recent videos

Talenom - Planned demerger and strategies of Talenom and Easor
2025-12-18 11:00 Talenom
Conference call with Fabege´s new CEO Bent Oustad
2025-12-18 10:00 Fabege
Investing in the life science sector
2025-12-18 07:47
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
2025-12-16 08:30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
2025-12-15 13:00 Truecaller
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.